The NMD Pharma story
NMD Pharma discovers and develops novel therapeutics for neuromuscular diseases.
NMD Pharma has a unique experimental platform focusing on ion channel function and electrophysiology of skeletal muscle. We develop small molecule inhibitors of skeletal muscle-specific ClC-1 ion channels that have a promising therapeutic potential in a range of neuromuscular diseases in which muscle activation is failing leading to muscle weakness and excessive fatigue that compromise the ability of patients to conduct essential human behaviour and cause lack of independence.
Our initial focus is on myasthenia gravis, spinal muscular atrophy, Charcot-Marie Tooth’s disease, and sarcopenia. Each of these diseases has a profound impact on patient's functional level and their overall quality of life.
Management team, board and founders
Our team is comprised of experts and leaders from around the world dedicated to developing novel treatments to improve muscle function and quality of life of patients with neuromuscular disease. Learn more about the management team, board and founders
Pipeline
We are working to develop novel small molecule inhibitors of skeletal muscle-specific ClC-1 ion channels that can be applied to a large range of clinical indications and orphan human diseases.
Investors
NMD Pharma raised $47M in one of the largest Series A in Europe from four large funds to advance ClC-1 inhibitor drugs to human clinical trials.
Careers
Interested in a career in neuromuscular disease research and drug development? Check out our available roles.
‘An active future made possible by the power of science’
NMD Pharma wins EY Entrepreneur Of The Year 2022 in the Life Sciences category
EY Entrepreneur Of The Year is the world's largest and most recognized growth creator competition. It is a celebration of the entrepreneurs who build and run successful and dynamic companies. More info
Watch the EY Entrepreneur Of The Year 2022 finalist video here
NMD Pharma wins the INCUBA award ‘Startup of the Year 2022’
The INCUBA award is an initiative that pays tribute to the investors and startups who take the lead and inspire others with their efforts in the startup ecosystem of Central Jutland. The award highlights startups and investors who deliver significant results and contribute to pushing the local ecosystem forward. It focuses on success, ambition, courage, innovation and those who go the extra mile for their business or investments. More info